0001293301-14-000005.txt : 20140124 0001293301-14-000005.hdr.sgml : 20140124 20140124165813 ACCESSION NUMBER: 0001293301-14-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140122 FILED AS OF DATE: 20140124 DATE AS OF CHANGE: 20140124 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FOREST LABORATORIES INC CENTRAL INDEX KEY: 0000038074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 111798614 STATE OF INCORPORATION: DE FISCAL YEAR END: 0913 BUSINESS ADDRESS: STREET 1: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212)421-7850 MAIL ADDRESS: STREET 1: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynch Jerome CENTRAL INDEX KEY: 0001509230 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-05438 FILM NUMBER: 14546563 MAIL ADDRESS: STREET 1: C/O FOREST LABORATORIES, INC. STREET 2: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-01-22 0000038074 FOREST LABORATORIES INC FRX 0001509230 Lynch Jerome C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK NY 10022 0 1 0 0 SVP-Sales Common Stock 2014-01-22 4 M 0 15000 42.535 A 81577 D Common Stock 2014-01-22 4 M 0 25000 51.535 A 106577 D Common Stock 2014-01-22 4 M 0 12500 37.255 A 119077 D Common Stock 2014-01-22 4 M 0 20000 24.12 A 139077 D Common Stock 2014-01-22 4 M 0 12000 31.265 A 151077 D Common Stock 2014-01-22 4 M 0 22500 32.165 A 173577 D Common Stock 2014-01-22 4 M 0 22700 29.995 A 196277 D Common Stock 2014-01-22 4 M 0 5925 34.035 A 202202 D Common Stock 2014-01-22 4 S 0 135625 67.2752 D 66577 D Stock Option (Right to Buy) 42.535 2014-01-22 4 M 0 15000 D 2005-12-13 2014-12-13 Common Stock 15000 0 D Stock Option (Right to Buy) 51.535 2014-01-22 4 M 0 25000 D 2007-12-07 2016-12-08 Common Stock 25000 0 D Stock Option (Right to Buy) 37.255 2014-01-22 4 M 0 12500 D 2008-12-06 2017-12-05 Common Stock 12500 0 D Stock Option (Right to Buy) 24.12 2014-01-22 4 M 0 20000 D 2009-12-08 2018-12-08 Common Stock 20000 0 D Stock Option (Right to Buy) 31.265 2014-01-22 4 M 0 12000 D 2010-12-07 2019-12-06 Common Stock 12000 8000 D Stock Option (Right to Buy) 32.165 2014-01-22 4 M 0 22500 D 2011-12-06 2020-12-05 Common Stock 22500 27500 D Stock Option (Right to Buy) 29.995 2014-01-22 4 M 0 22700 D 2012-12-05 2021-12-04 Common Stock 22700 22700 D Stock Option (Right to Buy) 34.035 2014-01-22 4 M 0 5925 D 2013-05-07 2022-05-06 Common Stock 5925 17775 D This amount includes shares of common stock which are subject to a risk of forfeiture. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.66, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Not Applicable. Exhibit List: Exhibit 24 - Power of Attorney /s/ Rita Weinberger as attorney-in-fact for Jerome Lynch 2014-01-24 EX-24 2 lynchpoa.htm POWER OF ATTORNEY - JEROME LYNCH

POWER OF ATTORNEY

        Know all by these presents that the undersigned hereby constitutes and appoints each of Rita Weinberger and Michael Nofi of FOREST LABORATORIES, INC. (the "Company") and Melissa Cooper of Dornbush Schaeffer Strongin & Venaglia, LLP, or any of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of the Company, Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the U.S. Securities and Exchange Commission (the "SEC") and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

        The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

        This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.



IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 12th day of December, 2013.



/s/ Jerome Lynch